Panagram AAA CLO ETF | |
Schedule of Investments | |
November 30, 2024 (Unaudited) | |
| |
COLLATERALIZED LOAN OBLIGATIONS - 93.5% (a) | | Par | | | Value | |
Bermuda - 1.0% | |
OHA Credit Funding 17 Ltd., Series 2024-17A, Class A, 6.10% (3 mo. Term SOFR + 1.48%), 04/20/2037 (b) | | $ | 850,000 | | | $ | 855,507 | |
| | | | | | | | |
Cayman Islands - 82.7%(c) | |
AGL CLO 12 Ltd., Series 2021-12A, Class A1, 6.04% (3 mo. Term SOFR + 1.42%), 07/20/2034 (b) | | | 800,000 | | | | 800,687 | |
Aimco CLO 10 Ltd., Series 2019-10A, Class ARR, 6.04% (3 mo. Term SOFR + 1.41%), 07/22/2037 (b) | | | 900,000 | | | | 903,272 | |
Apidos CLO XXXII Ltd., Series 2019-32A, Class A1R, 5.72% (3 mo. Term SOFR + 1.10%), 01/20/2033 (b) | | | 1,000,000 | | | | 1,001,750 | |
Apidos CLO XXXVII Ltd., Series 2021-37A, Class A, 6.02% (3 mo. Term SOFR + 1.39%), 10/22/2034 (b) | | | 1,500,000 | | | | 1,504,094 | |
Ares LVI CLO Ltd., Series 2020-56A, Class AR, 6.05% (3 mo. Term SOFR + 1.42%), 10/25/2034 (b) | | | 2,000,000 | | | | 2,001,774 | |
Ares LXI CLO Ltd., Series 2021-61A, Class A1R, 6.15% (3 mo. Term SOFR + 1.53%), 04/20/2037 (b) | | | 1,500,000 | | | | 1,510,947 | |
Ares XLI CLO Ltd., Series 2016-41A, Class AR2, 5.99% (3 mo. Term SOFR + 1.33%), 04/15/2034 (b) | | | 900,000 | | | | 901,767 | |
Bain Capital Credit CLO 2017-2 Ltd., Series 2017-2A, Class A1R3, 6.03% (3 mo. Term SOFR + 1.40%), 07/25/2037 (b) | | | 2,000,000 | | | | 2,010,894 | |
Bain Capital Credit CLO 2024-2 Ltd., Series 2024-2A, Class A1, 6.18% (3 mo. Term SOFR + 1.52%), 07/15/2037 (b) | | | 3,000,000 | | | | 3,021,168 | |
Ballyrock CLO 18 Ltd., Series 2021-18A, Class A1, 6.07% (3 mo. Term SOFR + 1.41%), 01/15/2035 (b) | | | 1,115,000 | | | | 1,116,516 | |
Basswood Park CLO Ltd., Series 2021-1A, Class A, 5.88% (3 mo. Term SOFR + 1.26%), 04/20/2034 (b) | | | 1,250,000 | | | | 1,251,370 | |
Benefit Street Partners CLO X Ltd., Series 2016-10A, Class A1RR, 6.09% (3 mo. Term SOFR + 1.47%), 04/20/2034 (b) | | | 2,000,000 | | | | 2,005,108 | |
Benefit Street Partners CLO XXI Ltd., Series 2020-21A, Class A1R, 6.09% (3 mo. Term SOFR + 1.43%), 10/15/2034 (b) | | | 1,000,000 | | | | 1,001,235 | |
Carlyle US CLO 2020-2 Ltd., Series 2020-2A, Class A1R, 6.03% (3 mo. Term SOFR + 1.40%), 01/25/2035 (b) | | | 900,000 | | | | 901,690 | |
Carlyle US CLO 2021-2 Ltd., Series 2021-2A, Class A1, 5.96% (3 mo. Term SOFR + 1.34%), 04/20/2034 (b) | | | 2,055,000 | | | | 2,058,929 | |
Carlyle US CLO 2021-4 Ltd., Series 2021-4A, Class A1, 5.99% (3 mo. Term SOFR + 1.37%), 04/20/2034 (b) | | | 1,200,000 | | | | 1,203,697 | |
CIFC Funding 2017-I Ltd., Series 2017-1A, Class ARR, 6.17% (3 mo. Term SOFR + 1.55%), 04/21/2037 (b) | | | 835,000 | | | | 841,778 | |
CIFC Funding 2020-II Ltd., Series 2020-2A, Class AR, 6.05% (3 mo. Term SOFR + 1.43%), 10/20/2034 (b) | | | 1,500,000 | | | | 1,501,696 | |
CIFC Funding 2020-IV Ltd., Series 2020-4A, Class A, 6.24% (3 mo. Term SOFR + 1.58%), 01/15/2034 (b) | | | 800,000 | | | | 801,520 | |
CIFC Funding 2022-II Ltd., Series 2022-2A, Class A1, 5.94% (3 mo. Term SOFR + 1.32%), 04/19/2035 (b) | | | 800,000 | | | | 802,352 | |
Clover CLO 2020-1 Ltd., Series 2020-1A, Class A1RR, 6.05% (3 mo. Term SOFR + 1.39%), 07/15/2037 (b) | | | 1,000,000 | | | | 1,005,233 | |
Elmwood CLO 26 Ltd., Series 2024-1A, Class A1, 6.13% (3 mo. Term SOFR + 1.50%), 04/18/2037 (b) | | | 850,000 | | | | 855,800 | |
Elmwood CLO V Ltd., Series 2020-2A, Class ARR, 6.38% (3 mo. Term SOFR + 1.37%), 10/20/2037 (b) | | | 1,500,000 | | | | 1,506,386 | |
Elmwood CLO XII Ltd., Series 2021-5A, Class AR, 5.93% (3 mo. Term SOFR + 1.36%), 10/15/2037 (b) | | | 900,000 | | | | 905,030 | |
Flatiron CLO 25 Ltd., Series 2024-2A, Class A, 5.62% (3 mo. Term SOFR + 1.35%), 10/17/2037 (b) | | | 3,000,000 | | | | 3,015,993 | |
Generate CLO Ltd., Series 2024-17A, Class A1, 6.53% (3 mo. Term SOFR + 1.40%), 10/22/2037 (b) | | | 3,000,000 | | | | 3,014,904 | |
Goldentree Loan Management US CLO 22 Ltd., Series 2024-22A, Class A, 5.94% (3 mo. Term SOFR + 1.33%), 10/20/2037 (b) | | | 3,000,000 | | | | 3,012,585 | |
Goldentree Loan Management US CLO 6 Ltd., Series 2019-6A, Class AR, 5.94% (3 mo. Term SOFR + 1.32%), 04/20/2035 (b) | | | 1,250,000 | | | | 1,248,406 | |
Harriman Park CLO Ltd., Series 2020-1A, Class A1R, 6.00% (3 mo. Term SOFR + 1.38%), 04/20/2034 (b) | | | 900,000 | | | | 902,709 | |
Madison Park Funding LXII Ltd., Series 2022-62A, Class AR, 6.50% (3 mo. Term SOFR + 1.85%), 07/17/2036 (b) | | | 2,000,000 | | | | 2,008,342 | |
Madison Park Funding XXX Ltd., Series 2018-30A, Class A1R, 6.01% (3 mo. Term SOFR + 1.36%), 07/16/2037 (b) | | | 900,000 | | | | 904,263 | |
Madison Park Funding XXXIV Ltd., Series 2019-34A, Class A1RR, 6.02% (3 mo. Term SOFR + 1.37%), 10/16/2037 (b) | | | 2,000,000 | | | | 2,010,160 | |
Magnetite XXVII Ltd., Series 2020-28A, Class AR, 6.01% (3 mo. Term SOFR + 1.39%), 01/20/2035 (b) | | | 1,000,000 | | | | 1,000,277 | |
Neuberger Berman Loan Advisers CLO 39 Ltd., Series 2020-39A, Class A1R, 6.15% (3 mo. Term SOFR + 1.53%), 04/20/2038 (b) | | | 1,250,000 | | | | 1,258,413 | |
Neuberger Berman Loan Advisers CLO 43 Ltd., Series 2021-43A, Class A, 6.04% (3 mo. Term SOFR + 1.39%), 07/17/2035 (b) | | | 900,000 | | | | 901,678 | |
OCP CLO 2019-17 Ltd., Series 2019-17A, Class AR2, 6.02% (3 mo. Term SOFR + 1.40%), 07/20/2037 (b) | | | 1,250,000 | | | | 1,255,671 | |
OCP CLO 2021-22 Ltd., Series 2021-22A, Class AR, 5.91% (3 mo. Term SOFR + 1.35%), 10/20/2037 (b) | | | 3,000,000 | | | | 3,016,332 | |
Octagon Investment Partners 29 Ltd., Series 2016-1A, Class A1R2, 6.05% (3 mo. Term SOFR + 1.42%), 07/18/2037 (b) | | | 2,000,000 | | | | 2,010,774 | |
OHA Credit Funding 10 Ltd., Series 2021-10A, Class A, 6.02% (3 mo. Term SOFR + 1.39%), 01/18/2036 (b) | | | 800,000 | | | | 801,428 | |
OHA Credit Funding 5 Ltd., Series 2020-5A, Class AR, 6.13% (3 mo. Term SOFR + 1.35%), 10/18/2037 (b) | | | 3,000,000 | | | | 3,016,176 | |
OHA Credit Partners XVI Ltd., Series 2021-16A, Class AR, 5.98% (3 mo. Term SOFR + 1.35%), 10/18/2037 (b) | | | 1,975,000 | | | | 1,985,801 | |
Palmer Square CLO 2019-1 Ltd., Series 2019-1A, Class A1R, 5.93% (3 mo. Term SOFR + 1.41%), 11/14/2034 (b) | | | 890,000 | | | | 892,825 | |
Palmer Square CLO 2023-1 Ltd., Series 2023-1A, Class A, 6.52% (3 mo. Term SOFR + 1.90%), 01/20/2036 (b) | | | 2,000,000 | | | | 2,006,744 | |
Palmer Square CLO Ltd., Series 2024-3A, Class A, 6.54% (3 mo. Term SOFR + 1.35%), 07/20/2037 (b) | | | 1,500,000 | | | | 1,505,693 | |
Reese Park CLO Ltd., Series 2020-1A, Class AR, 6.05% (3 mo. Term SOFR + 1.39%), 10/15/2034 (b) | | | 800,000 | | | | 801,024 | |
Regatta XVIII Funding Ltd., Series 2021-1A, Class A1, 6.02% (3 mo. Term SOFR + 1.36%), 01/15/2034 (b) | | | 1,500,000 | | | | 1,502,663 | |
Rockland Park CLO Ltd., Series 2021-1A, Class A, 6.00% (3 mo. Term SOFR + 1.38%), 04/20/2034 (b) | | | 1,200,000 | | | | 1,203,697 | |
Sixth Street CLO XV Ltd., Series 2020-15A, Class AR, 6.20% (3 mo. Term SOFR + 1.37%), 10/24/2037 (b) | | | 1,000,000 | | | | 1,003,496 | |
Wellman Park CLO Ltd., Series 2021-1A, Class AR, 6.01% (3 mo. Term SOFR + 1.35%), 07/15/2037 (b) | | | 1,200,000 | | | | 1,204,550 | |
| | | | | | | 72,899,297 | |
| | | | | | | | |
Jersey - 9.8% | |
Ares Loan Funding IV Ltd., Series 2023-ALF4A, Class A1, 6.41% (3 mo. Term SOFR + 1.75%), 10/15/2036 (b) | | | 2,000,000 | | | | 2,013,592 | |
Birch Grove CLO 8 Ltd., Series 2024-8A, Class A1, 6.25% (3 mo. Term SOFR + 1.63%), 04/20/2037 (b) | | | 900,000 | | | | 907,988 | |
Danby Park CLO Ltd., Series 2022-1A, Class AR, 5.98% (3 mo. Term SOFR + 1.36%), 10/21/2037 (b) | | | 2,000,000 | | | | 2,010,358 | |
Elmwood CLO 15 Ltd., Series 2022-2A, Class A1, 5.97% (3 mo. Term SOFR + 1.34%), 04/22/2035 (b) | | | 880,000 | | | | 881,574 | |
Neuberger Berman Loan Advisers NBLA CLO 52 Ltd., Series 2022-52A, Class AR, 5.99% (3 mo. Term SOFR + 1.35%), 10/24/2038 (b) | | | 2,000,000 | | | | 2,014,300 | |
Symphony CLO 35 Ltd., Series 2022-35A, Class AR, 6.34% (3 mo. Term SOFR + 1.70%), 10/24/2036 (b) | | | 850,000 | | | | 854,210 | |
| | | | | | | 8,682,022 | |
TOTAL COLLATERALIZED LOAN OBLIGATIONS (Cost $82,107,711) | | | | 82,436,826 | |
| | | | | | | | |
TOTAL INVESTMENTS - 93.5% (Cost $82,107,711) | | | | 82,436,826 | |
Money Market Deposit Account - 5.7% (d) | | | | 5,046,427 | |
Other Assets in Excess of Liabilities - 0.8% | | | | 663,502 | |
TOTAL NET ASSETS - 100.0% | | | | | | $ | 88,146,755 | |
two | | | | – | % |
Percentages are stated as a percent of net assets. | | | | – | % |
The following is a summary of the Fund’s pricing procedures. It is intended to be a general discussion and may not necessarily reflect all the pricing procedures followed by the Fund.
Fixed income securities, including short-term debt instruments having a maturity less than 60 days, are valued at the evaluated mean price supplied by an approved independent third-party pricing service (“Pricing Service”). These securities are categorized in Level 2 of the fair value hierarchy.
In the case of foreign securities, the occurrence of events after the close of foreign markets, but prior to the time the Fund’s NAV is calculated will result in an adjustment to the trading prices of foreign securities when foreign markets open on the following business day. The Fund will value foreign securities at fair value, taking into account such events in calculating the NAV. In such cases, use of fair valuation can reduce an investor’s ability to seek profit by estimating the Fund’s NAV in advance of the time the NAV is calculated. These securities are categorized in Level 2 of the fair value hierarchy.
The Board of Trustees (the "Board”) has adopted a pricing and valuation policy for use by the Fund and its Valuation Designee (as defined below) in calculating the Fund’s NAV. Pursuant to Rule 2a-5 under the 1940 Act, the Fund has designated Panagram Structured Asset Management, LLC as its “Valuation Designee” to perform all of the fair value determinations as well as to perform all of the responsibilities that may be performed by the Valuation Designee in accordance with Rule 2a-5. The Valuation Designee is authorized to make all necessary determinations of the fair values of the portfolio securities and other assets for which market quotations are not readily available or if it is deemed that the prices obtained from brokers and dealers or independent pricing services are unreliable.
The Fund has adopted authoritative fair value accounting standards which establish an authoritative definition of fair value and set out a hierarchy for measuring fair value. These standards require additional disclosures about the various inputs and valuation techniques used to develop the measurements of fair value, a discussion in changes in valuation techniques and related inputs during the period and expanded disclosure of valuation levels for major security types. These inputs are summarized in the three broad levels listed below:
Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.
Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
Level 3 – Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund’s own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available.
The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
The following table is a summary of the inputs used to value the Fund’s securities by level within the fair value hierarchy as of November 30, 2024: